"sra_experiment_id","gse_accession","gsm_accession","species","sequencing_technique","sample_type","cell_line_name","tissue_type","disease_description","treatment","is_chipseq_related_experiment","chipseq_antibody_target","scientific_sample_summary"
"SRX6952594","GSE138460","GSM4109388","Homo sapiens","RNA-Seq","Cell Line","LASCPC1","N/A","Prostate neuroendocrine","Enzalutamide + GSK126","no","N/A","This sample represents a human prostate cancer cell line (LASCPC1) treated with Enzalutamide and GSK126, analyzed using RNA-Seq to study gene expression changes in response to these treatments."
